70 results
Page 2 of 4
8-K
EX-1.1
akdedlcg oecxp6
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
h17w1n w2
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
7jyngeq
25 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-1.1
sb89r0
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
ec9wzqsgp4e15ts8esbq
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
yb5698ui3160bm4
10 Dec 21
Prospectus supplement for primary offering
5:25pm
CORRESP
zbz2ipy
9 Dec 21
Correspondence with SEC
12:00am
424B5
0vegra6u232vt2i j4
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
r0z2e1l10f9n7z1jo03l
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm